Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
OTC: SHEZF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Li Li
- Employees
- 1,926
- Headquarters
- Shenzhen, China
- IPO year
- 2021
- Market cap
- $689.0M
- Website
- https://www.hepalink.com
Loading SHEZF…
Loading profile data…Frequently asked questions about SHEZF
What does Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) do?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd., established in 1998 and headquartered in Shenzhen, People's Republic of China, operates as a global pharmaceutical enterprise. Having adopted its current name in February 2017 (formerly Shenzhen Hepalink Pharmaceutical Co.,Ltd.), the company specializes in the production and worldwide distributio...
Where does SHEZF trade?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) trades on the Other OTC.
What sector is SHEZF in?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Shenzhen Hepalink Pharmaceutical Group Co., Ltd.?
Li Li is the chief executive officer of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF).
Where is Shenzhen Hepalink Pharmaceutical Group Co., Ltd. headquartered?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is headquartered in China.
Does SHEZF pay a dividend?
Yes — Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) paid a trailing twelve-month dividend of USD 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SHEZF go public?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) completed its initial public offering in 2021.